Please wait a minute...
Journal of ZheJiang University(Medical Science)  2017, Vol. 46 Issue (5): 468-472    DOI: 10.3785/j.issn.1008-9292.2017.10.03
    
Research progress of CT/MRI parametric response map in precision evaluation of therapeutic response of cancer patients
ZHANG Siying, CHEN Feng
Department of Radiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China
Download:   PDF(969KB)
Export: BibTeX | EndNote (RIS)      

Abstract  

Intratumor spatial heterogeneity has been ignored in evaluating tumor therapeutic effect with conventional imaging methods. The voxel-based parametric response map (PRM) derived from CT or MRI may accurately, objectively and timely evaluate the tumor response to therapy, by comparing changes of the functional parameters before and after treatment. This approach may improve the imaging monitoring and the sensitivity of spatial resolution related to tumor changes after treatment. Thus, PRM may help to improve the treatment plan and prognosis evaluation for patients. This article reviews progress on CT/MRI PRM in precision evaluation of therapeutic response of cancer patients.



Key wordsTomography,X-ray computed      Image interpretation,computer-assisted      Neoplasms      Treatment outcome      Diagnostic imaging      Review      Magnetic resonance imaging     
Received: 22 May 2017      Published: 25 October 2017
CLC:  R445  
  R73  
Cite this article:

ZHANG Siying, CHEN Feng. Research progress of CT/MRI parametric response map in precision evaluation of therapeutic response of cancer patients. Journal of ZheJiang University(Medical Science), 2017, 46(5): 468-472.

URL:

http://www.zjujournals.com/xueshu/med/10.3785/j.issn.1008-9292.2017.10.03     OR     http://www.zjujournals.com/xueshu/med/Y2017/V46/I5/468


CT和磁共振参数反应图在肿瘤精准疗效评估中的研究进展

传统影像学方法在评估肿瘤疗效时忽略了肿瘤内部空间反应的异质性,而基于逐个体素分析的CT和磁共振参数反应图通过对比肿瘤治疗前与治疗后(中)的功能参数差异,能较及时、客观、准确地评价肿瘤对治疗的反应,提高了肿瘤治疗相关变化的影像监测及其空间分辨的敏感度,有助于患者治疗方案的改进和预后评估。本文主要对CT和磁共振参数反应图及其在肿瘤精准疗效评估中的研究进展进行综述。


关键词: 磁共振成像,  体层摄影术,X线计算机,  诊断显像,  治疗结果,  综述,  肿瘤,  图像解释,计算机辅助 
[[1]]   PADHANI A R, MILES K A. Multiparametric imaging of tumor response to therapy[J]. Radiology,2010,256(2):348-364.
[[2]]   THOENY H C, DE KEYZER F, CHEN F, et al. Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats[J]. Radiology,2005,234(3):756-764.
[[3]]   KANG Y, CHOI S H, KIM Y J, et al. Gliomas:Histogram analysis of apparent diffusion coefficient maps with standard-or high-b-value diffusion-weighted MR imaging-correlation with tumor grade[J]. Radiology,2011,261(3):882-890.
[[4]]   FOZOUNI N, CHOPP M, NEJAD-DAVARANIS P, et al. Characterizing brain structures and remodeling after TBI based on information content, diffusion entropy[J/OL]. PLoS One,2013,8(10):e76343.
[[5]]   BAEK H J, KIM H S, KIM N, et al. Percent change of perfusion skewness and kurtosis:a potential imaging biomarker for early treatment response in patients with newly diagnosed glioblastomas[J]. Radiology,2012,264(3):834-843.
[[6]]   MOFFAT B A, CHENEVERT T L, LAWRENCE T S, et al. Functional diffusion map:a noninvasive MRI biomarker for early stratification of clinical brain tumor response[J]. Proc Natl Acad Sci U S A,2005,102(15):5524-5529.
[[7]]   GALBÁN C J, CHENEVERT T L, MEYER C R, et al. The parametric response map is an imaging biomarker for early cancer treatment outcome[J]. Nat Med,2009,15(5):572-576.
[[8]]   GALBÁN C J, MUKHERJI S K, CHENEVERT T L, et al. A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy[J]. Transl Oncol,2009,2(3):184-190.
[[9]]   ALIC L, VAN VLIET M, VAN DIJKE C F, et al. Heterogeneity in DCE-MRI parametric maps:a biomarker for treatment response?[J]. Phys Med Biol,2011,56(6):1601-1616.
[[10]]   GALBÁN C J, CHENEVERT T L, MEYER C R, et al. Prospective analysis of parametric response map-derived MRI biomarkers:identification of early and distinct glioma response patterns not predicted by standard radiographic assessment[J]. Clin Cancer Res,2011,17(14):4751-4760.
[[11]]   CHOI S J, KIM J, SEO J, et al. Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization[J]. Abdom Imaging,2014,39(3):518-525.
[[12]]   LI X, KANG H, ARLINGHAUSL R, et al. Analyzing spatial heterogeneity in DCE-and DW-MRI parametric maps to optimize prediction of pathologic response to neoadjuvant chemotherapy in breast cancer[J]. Transl Oncol,2014,7(1):14-22.
[[13]]   LONGO D L, DASTRÙ W, CONSOLINO L, et al. Cluster analysis of quantitative parametric maps from DCE-MRI:application in evaluating heterogeneity of tumor response to antiangiogenic treatment[J]. Magn Reson Imaging,2015,33(6):725-736.
[[14]]   CESCHIN R, KURLAND B F, ABBERBOCK S R, et al. Parametric response mapping of apparent diffusion coefficient as an imaging biomarker to distinguish pseudoprogression from true tumor progression in peptide-based vaccine therapy for pediatric diffuse intrinsic pontine glioma[J]. AJNR Am J Neuroradiol,2015,36(11):2170-2176.
[[15]]   CHOI S J, KIM J, SEO J, et al. Parametric response mapping of dynamic CT for predicting intrahepatic recurrence of hepatocellular carcinoma after conventional transcatheter arterial chemoembolization[J]. Eur Radiol,2016,26(1):225-234.
[[16]]   YOON R G, KIM H S, KIM D Y, et al. Apparent diffusion coefficient parametric response mapping MRI for follow-up of glioblastoma[J]. Eur Radiol,2016,26(4):1037-1047.
[[17]]   KICKINGEREDER P, RADBRUCH A, BURTH S, et al. MR perfusion-derived hemodynamic parametric response mapping of bevacizumab efficacy in recurrent glioblastoma[J]. Radiology,2016,279(2):542-552.
[[18]]   BAER A H, HOFF B A, SRINIVASAN A, et al. Feasibility analysis of the parametric response map as an early predictor of treatment efficacy in head and neck cancer[J]. AJNR Am J Neuroradiol,2015,36(4):757-762.
[[19]]   HAMSTRA D A, CHENEVERT T L, MOFFAT B A, et al. Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma[J]. Proc Natl Acad Sci U S A,2005,102(46):16759-16764.
[[20]]   JUST N. Improving tumour heterogeneity MRI assessment with histograms[J]. Br J Cancer,2014,111(12):2205-2213.
[[21]]   AQUINO D, DI S A L, SCOTTI A, et al. Parametric response maps of perfusion MRI may identify recurrent glioblastomas responsive to bevacizumab and irinotecan[J/OL]. PLoS One,2014,9(3):e90535.
[[22]]   LEMASSON B, GALBÁN C J, BOES J L, et al. Diffusion-weighted MRI as a biomarker of tumor radiation treatment response heterogeneity:a comparative study of whole-volume histogram analysis versus voxel-based functional diffusion map analysis[J]. Transl Oncol,2013,6(5):554-561.
[[23]]   FINK J, BORN D, CHAMBERLAINM C. Pseudoprogression:relevance with respect to treatment of high-grade gliomas[J]. Curr Treat Options Oncol,2011,12(3):240-252.
[1] XU Jingjing, TAN Yanbin, ZHANG Minming. Medical imaging in tumor precision medicine: opportunities and challenges[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 455-461.
[2] PAN Jingying, HE Mengye, KE Wei, HU Menglin, WANG Meifang, SHEN Peng. Advances on correlation of PET-CT findings with breast cancer molecular subtypes, treatment response and prognosis[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 473-480.
[3] YANG Rong, YAO Linpeng, ZHANG Siying, CHEN Feng. Rat endothelial progenitor cells labeled with Molday IONTM EverGreen and in vitro MRI study[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 481-486.
[4] FU Liping, CHENG Aiping, SUN Meiling, WANG Xiaogang, FU Jianlan. Value of 18F-FDG PET-CT in detection of primary lesion and pelvic lymph node metastasis in FIGO stages ⅠA2-ⅡA cervical cancer[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 517-522.
[5] LOU Zhaohan, FEI Xufeng, YAN Jianbo, JIA Qiaonjuan, HUANG Yijian, WU Jiaping. Geographic spatial pattern of digestive system cancers in Yiwu city[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 537-545.
[6] YE Hongrou, CHEN Chunxiao. Comparison of double-balloon endoscopy and multi-detector row computed tomography in diagnosis of small intestinal tumors[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 557-562.
[7] PAN Yao, CHEN Jieyu, YU Risheng. Accurate imaging diagnosis and evaluation of pancreatic cancer[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 462-467.
[8] LI Aijing, PAN Yuning, CHEN Bin, XIA Jianbi, GAN Fang, JIN Yinhua, ZHENG Jianjun. Association of parameters in dynamic contrast-enhanced MRI using reference region model with prognostic factors and molecular subtypes of breast cancer[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 505-510.
[9] ZHANG Ge'er, PAN Zimin. Gestational trophoblastic diseases in cesarean scar: an analysis of 20 cases[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 529-536.
[10] BIAN Wei, YAO Yuan, ZHANG Haijin, YE Xiaoqian, ZHANG Minming. Application of CT scan in diagnosis of pathological type and origin of metastatic ovarian tumors[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 546-551.
[11] DONG Fei, LI Qian, JIANG Biao, ZENG Qiang, HUA Jianming, ZHANG Minming. Quantitative analysis of enhanced MRI features for predicting epidermal growth factor receptor gene amplification in glioblastoma multiforme with radiomic method[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 492-497.
[12] WANG Subo, ZHAO Zhenhua, HU Hongjie, YANG Jianfeng, ZHAO Li, YANG Liming, WANG Cheng. Application of dynamic-contrast enhanced magnetic resonance pharmacokinetic models in differential diagnosis of cellular uterine leiomyoma[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 498-504.
[13] KUANG Pingding, DING Xinfa, XU Jingjing, ZHOU Qijing, ZHANG Minming. Diagnostic value of dual energy CT for lymph node metastasis in patients with non-small cell lung cancer[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 511-516.
[14] WANG Mengyan, ZHU Biao. Research progress on genes mutations related to sulfa drug resistance in Pneumocystis jirovecii[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 563-569.
[15] JIANG Yiqian, GUO Qingmin, GU Jianzhong, XU Xiaoping, AN Suhong, SU Fang, BAO Yanhong, HUANG Changxin, GUAN Xiaoxiang. Effect of microRNA-29b on proliferation and migration of breast cancer cells and its molecular mechanism[J]. Journal of ZheJiang University(Medical Science), 2017, 46(4): 349-356.